Meridian Bioscience Inc (NASDAQ:VIVO)
| 17.74 Delayed Data As of Nov 25 |  +0.44 / +2.54%Today’s Change | 5.51 Today|||52-Week Range 26.58 | +81.58% Year-to-Date |
Latest VIVO News | Press Releases
| Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Standard Motor Products, NIC and Azure Power Nov 20 / Zacks.com - Paid Partner Content | New Strong Buy Stocks For November 18th Nov 18 / Zacks.com - Paid Partner Content |
| Sail Through the Choppy Market With These 5 Low-Beta Stocks Nov 19 / Zacks.com - Paid Partner Content | Has Meridian Bioscience (VIVO) Outpaced Other Medical Stocks This Year? Nov 17 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 17.32 |
| Today’s open | 17.39 |
| Day’s range | 17.32 - 17.85 |
| Volume | 419,132 |
| Average volume (3 months) | 634,792 |
| Market cap | $814.4M |
Data as of 3:59pm ET, 11/25/2020
Growth & Valuation
| Earnings growth (last year) | +88.18% |
| Earnings growth (this year) | -3.97% |
| Earnings growth (next 5 years) | +17.00% |
| Revenue growth (last year) | +26.19% |
| P/E ratio | 17.4 |
| Price/Sales | 2.89 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QTNTQuotient Ltd | +0.38 | +5.88% |
| CLDXCelldex Therapeutics... | -0.50 | -2.25% |
| LNTHLantheus Holdings In... | -0.22 | -1.66% |
| AXDXAccelerate Diagnosti... | -0.08 | -0.97% |
Data as of 7:44pm ET, 11/25/2020
Financials
| Next reporting date | January 28, 2021 |
| EPS forecast (this quarter) | $0.29 |
| Annual revenue (last year) | $253.7M |
| Annual profit (last year) | $46.2M |
| Net profit margin | 18.21% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cincinnati, Ohio |
Forecasts
